Ephelis * is a freckle
June 2026 update: FDA issues 25 more warning letters to telehealth companies During the week of June 15, 2026 - days before this article was published - the FDA issued 25 additional warning letters to telehealth companies over false or misleading promotional claims about compounded GLP-1 products
Medication and Side Effect Monitoring Keep track of medication usage and side effects associated with Ozempic, Wegovy, Mounjaro, and other GLP-1 options
Through Ulta Lab Tests, patients can explore relevant metabolic, kidney, liver, blood-count, and nutrient tests, receive secure results, and use those findings to support a more informed conversation with a qualified healthcare provider
Individuals taking Wegovy, particularly older adults, may be at a higher risk of developing NAION and should seek medical attention immediately for blurred vision, blindness, or other sight concerns
Before the infusion begins, a brief health screening confirms candidacy, reviews current medications and any contraindications, and identifies customization preferences such as additional wellness boosters or adjusted dosages